drugset / Trial / NCT05366634
A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers
RandomizedSequentialSingle-blindBasic science
Summary
MDK-703-101 is a single ascending dose study, to determine the safety, tolerability, and PK/PD of MDK-703 in healthy adult subjects.
Timeline
- Start
- 2022-06-30
- Primary completion
- 2022-12-28
- Completion
- 2022-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MDK-703 | Unknown | — | Other |
Indications
No indication recorded.